The U.S. FDA has approved Novo Nordisk's Ozempic for reducing the risk of kidney failure and disease progression, as well as ...

Ozempic, the blockbuster GLP-1 drug that was originally approved to treat type 2 diabetes, has now also been approved by the ...

Ozempic, or semaglutide, can now be used to reduce the risk of worsening kidney disease or kidney failure in adults with type ...

Wall Street investors, spurred on by Trump's pro-business agenda, could be ignoring real risks posed by the president.

CNN’s Matt Egan reports on a new Chinese AI model called R1, which was created by the company DeepSeek. The R1 model is ...

Viatris has faced volatility since its 2020 formation but is now in Phase 2 of its transformation. Learn why VTRS stock could ...

According to a Nature Medicine study, weight loss drugs can be highly effective in improving several unexpected health ...

As demand for weight-loss injections sold under brand names such as Ozempic and Wegovy continues to soar, a study has ...

The tech firms that host the app are putting their shareholders at risk by failing to comply with the law.

Health care, ride sharing, and the emerging world of YouTube entertainers are among industries leading investors have picked ...

Novo Nordisk has faced a massive selloff in recent months amid disappointing drug trials and U.S. pressure to cut its prices.